ChemicalBook > Product Catalog >API >Hormones and the Endocrine System >Erectile Dysfunction Treatment >Darifenacin
Darifenacin
![Darifenacin Structure](CAS/GIF/133099-04-4.gif)
- CAS No.
- 133099-04-4
- Chemical Name:
- Darifenacin
- Synonyms
- CS-773;UK88525;UK-88525;UK 88525;DARIFENACIN;Darifenacin, >=98%;Darifenacin USP/EP/BP;Tolafentrine Impurity 16;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe
- CBNumber:
- CB1506695
- Molecular Formula:
- C28H30N2O2
- Molecular Weight:
- 426.55
- MOL File:
- 133099-04-4.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/2 8:55:01
Darifenacin Chemical Properties,Uses,Production
Uses
Treatment for an overactive bladder.
Definition
ChEBI: 2-[(3S)-1-Ethylpyrrolidin-3-yl]-2,2-diphenylacetamide in which one of the hydrogens at the 2-position of the ethyl group is substituted by a 2,3-dihydro-1-benzofuran-5-yl group. It is a selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, and is used as the hydrobromide salt in the management of urinary incontinence.
Darifenacin Preparation Products And Raw materials
Raw materials
1189753-52-3
2-Oxodarifenacin
5-(2-Bromoethyl)-2,3-dihydrobenzofuran
Darifenacin hydrobromide
3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine
chevron_left
1of3
chevron_rightPreparation Products
Global( 127)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Venkatasai Life Sciences | +91-9908134868 +91-8008303069 | Hyderabad, India | 186 | 58 | Inquiry |
Glenmark Pharmaceuticals Limited | +912240189999 | Maharashtra, India | 93 | 58 | Inquiry |
AKASH PHARMA EXPORTS | +91-9388123451 +91-9846039283 | Kerela, India | 470 | 58 | Inquiry |
Manus Aktteva | +91 (79) 6512-3395 | New Delhi, India | 581 | 34 | Inquiry |
Parth Antibiotics Pvt Ltd. | +91 (22) 2562-8329 | New Delhi, India | 173 | 50 | Inquiry |
OCEAN TRADING CORPORATION | +91(22) 24921669 | New Delhi, India | 6211 | 58 | Inquiry |
Lexine Technochem Private Limited | 07942564658 | Vadodara, India | 69 | 58 | Inquiry |
Abil Chem Pharma Private Limited | 08068442238Ext 530 | Mumbai, India | 5 | 58 | Inquiry |
P. R. Pharma Source Private Limited | 08048361295Ext 104 | Mumbai, India | 9 | 58 | Inquiry |
JSK Chemical | 98797 67970 | Gujarat, India | 291 | 58 | Inquiry |
133099-04-4(Darifenacin)Related Search:
2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetaMide
UK 88525
UK88525
UK-88525
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip
Darifenacin, >=98%
DARIFENACIN
2-[1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dipheny
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe
CS-773
3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, (3S)-
Darifenacin USP/EP/BP
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α-α-diphenyl-3-pyrrolidineacetamide Hydrobromide
Tolafentrine Impurity 16
133099-04-4
Pharmaceutical material and intermeidates
API